• Seenivasan Karthiga Devi
  • Devadasan Velmurugan


Methyltransferase, human dihydrofolate reductase, and acidic mammalian chitinase are the potential targets for the viral, malarial and inflammatory
diseases, respectively. Hence, it is of interest to screen the natural compounds against these proteins using molecular docking. In this study,
pharmacophore modeling was performed on marine compounds against these diseases using PHASE module. This resulted in the common
pharmacophore hypothesis AADRR.7f, which might be responsible for the biological activity: Two acceptor (A) groups (−C=O), one donor (O-H)
and two aromatic rings (R). The three-dimensional-quantitative structure activity relationship model obtained has the correlation coefficient values
q2=0.67; pred r2=0.86. In addition, molecular docking studies were performed. The model developed may serve as a query tool for future virtual
screening and drug designing for these targets. Marine compounds from the different marine sources such as alga, bacterium, sponges, soft corals, sea
cucumber, and clam have been selected from the literature.

Keywords: Molecular modeling, Quantitative structure activity relationship, Pharmacophore, Methyltransferase, Human dihydrofolate reductase,
Acidic mammalian chitinase, Absorption, distribution, metabolism and excretion, Docking, Structure based drug design.


Carté BK. Biom edical potential of marine natural products. Biosciences


Halvorson HO. Aquaculture, marine sciences and oceanography:

A confluence connection. New Engl J Higher Educ Econ Dev


Faulkner DJ. Chemical riches from the Ocean. Chem Brit 1995;???:680-4.

Scheuer PJ, Lazarovici P, Spira ME, Eliahu Z, editors. Marine

metabolites as drug leads-retrospect and prospect. In: Biochemical

Aspects of Marine Pharmacology. Fort Collins, Colorado: Alaken, Inc.;

p. 1-12.

Lindenbach BD, Rice CM. Flaviviridae: The viruses and their

replication. In: Knipe DM, Howley PM, editors. Fields Virology. 4th ed.

Philadelphia: Lippincott Williams & Wilkins; 2001. p. 991-1041.

Burke DS, Monath TP. Flaviviruses. In: Knipe DM, Howley PM.

editors. Fields Virology. 4th ed., Vol. 1. Philadelphia, PA: Lippincott

William & Wilkins; 2001. p. 1043-126.

Laport MS, Santos OC, Muricy G. Marine sponges: Potential sources of

new antimicrobial drugs. Curr Pharm Biotechnol 2009;10(1):86-105.

De Clercq E. Antiviral drugs: Current state of the art. J Clin Virol


Donia M, Hamann MT. Marine natural products and their potential

applications as anti-infective agents. Lancet Infect Dis 2003;3(6):338-48.

Sipkema D, Franssen MC, Osinga R, Tramper J, Wijffels RH. Marine

sponges as pharmacy. Mar Biotechnol (NY). 2005;7:142-62.

Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR. Marine

natural products. Nat Prod Rep 2003;20(1):1-48.

Faulkner DJ. Marine natural products. Nat Prod Rep 2002;19(1):1-48.

Egloff MP, Decroly E, Malet H, Selisko B, Benarroch D, Ferron F, et al.

Structural and functional analysis of methylation and 5’-RNA sequence

requirements of short capped RNAs by the methyltransferase domain of

dengue virus NS5. J Mol Biol 2007;372(3):723-36.

Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, et al. West Nile virus

’-cap structure is formed by sequential guanine N-7 and ribose 2’-O

methylations by nonstructural protein 5. J Virol 2006;80(17):8362-70.

Dong H, Ren S, Zhang B, Zhou Y, Puig-Basagoiti F, Li H, et al.

West Nile virus methyltransferase catalyzes two methylations of the

viral RNA cap through a substrate-repositioning mechanism. J Virol


Dong H, Liu L, Zou G, Zhao Y, Li Z, Lim SP, et al. Structural and

functional analyses of a conserved hydrophobic pocket of flavivirus

methyltransferase. J Biol Chem 2010;285(42):32586-95.

Mishra SK, Satpathy SK, Mohanty S. Survey of malaria treatment and

deaths. Bull World Health Organ 1999;77(12):1020.

de Souza-Neiras WC, de Melo LM, Machado RL. The genetic

diversity of Plasmodium vivax – A review. Mem InstOswaldo Cruz


Vennerstrom JL, Arbe-Barnes S, Brun R, Charman SA, Chiu FC,

Chollet J, et al. Identification of an antimalarial synthetic trioxolane

drug development candidate. Nature 2004;430(7002):900-4.

Goodsell, David. RCSB PDB-101. RCSB PDB, Oct. 2002.

Venkata M, Sripathy R, Anjana D, Somashekara N, Krishnaraju A,

Krishanu S, et al. In silico in vitro and in vivo assessment of safety and

anti-inflammatory activity of curcumin. Am J Infect Dis 2012;8(1):26-33.

Bussink AP, Speijer D, Aerts JM, Boot RG. Evolution of mammalian

chitinase(-like) members of family 18 glycosyl hydrolases. Genetics


Boot RG, Blommaart EF, Swart E, Ghauharali-van der Vlugt K, Bijl N,

Moe C, et al. Identification of a novel acidic mammalian chitinase

distinct from chitotriosidase. J Biol Chem 2001;276(9):6770-8.

Sakuda S, Isogai A, Matsumoto S, Suzuki A, Koseki K. The structure

of allosamidin, a novel insect chitinase inhibitor, produced by

Streptomyces sp. Tetrahedron Lett 1986;27:2475-8.

Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L, et al. Acidic

mammalian chitinase in asthmatic Th2 inflammation and IL-13

pathway activation. Science 2004;304(5677):1678-82.

Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM,

et al. Predominant TH2-like bronchoalveolar T-lymphocyte population

in atopic asthma. N Engl J Med 1992;326(5):298-304.

Van de Waterbeemd H, Carter RE, Grassy G, et al. Glossary of terms used

in computational drug design. Pure Appl Chem 1997;69(5):1137-52.

Marriott DP, Dougall IG, Meghani P, Liu YJ, Flower DR. Lead

generation using pharmacophore mapping and three-dimensional

database searching: Application to muscarinic M(3) receptor

antagonists. J Med Chem 1999;42(17):3210-6.

Glide Version 5.8. New York, NY: Schrödinger, LLC; 2009.

Mayer AM, Rodríguez AD, Taglialatela-Scafati O, Fusetani N.

Marine pharmacology in 2009-2011: Marine compounds with

antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal,

antituberculosis, and antiviral activities; Affecting the immune and

nervous systems, and other miscellaneous mechanisms of action. Mar

Drugs 2013;11(7):2510-73.

Mayer AM, Hamann MT. Marine pharmacology in 2000: Marine

compounds with antibacterial, anticoagulant, antifungal, antiinflammatory,

antimalarial, antiplatelet, antituberculosis, and antiviral

activities; affecting the cardiovascular, immune, and nervous systems

and other miscellaneous mechanisms of action. Mar Biotechnol (NY)


Cody V, Galitsky N, Luft JR, Pangborn W, Gangjee A. Analysis of two

polymorphic forms of a pyrido[2,3-d] pyrimidine N9-C10 reversedbridge

antifolate binary complex with human dihydrofolate reductase.

Acta Crystallogr D Biol Crystallogr 2003;59(Pt 4):654-61.

Sutherland TE, Andersen OA, Betou M, Eggleston IM, Maizels RM,

van Aalten D, et al. Analyzing airway inflammation with chemical

biology: Dissection of acidic mammalian chitinase function with a

selective drug-like inhibitor. Chem Biol 2011;18(5):569-79.

Daddam JR, Daddam MR, Dakinedi SR. Phytochemical screening and

in silico approach for the identification of anti-stress compounds from

medicinal plants. Int J Appl Biol Pharm Technol 2013;4:324-34.

Sherman W, Day T, Jacobson MP, Friesner RA, Farid R. Novel

procedure for modeling ligand/receptor induced fit effects. J Med Chem




How to Cite

Karthiga Devi, S., and D. Velmurugan. “MOLECULAR MODELLING, QSAR AND PHARMACOPHORE STUDIES ON ANTI-VIRAL, ANTI-MALARIAL AND ANTI-INFLAMMATORY BIOACTIVE COMPOUNDS FROM MARINE SOURCES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 8, no. 3, May 2015, pp. 36-43,



Review Article(s)